We are the first company to bundle pharmacogenetic testing in a platform focused on benefiting patients, providers, and facility operators. Our goal is to reduce adverse drug events and overall patient drug costs and provide higher-quality metrics for healthcare providers across the board. We work closely with health systems, patients, long-term care, and physicians to deliver improved outcomes.
MyBestMed® helps identify potential and preventable adverse reactions to prescription medications. Health systems can benefit from implementing pharmacogenetic (PGx) programs by increasing value-based metrics such as reducing cost-of-care and improving patient outcomes. We integrate with all legacy EHR systems so we don’t impact provider workflows to improve adoption. Using PGx has proven in multiple studies to be a huge win for patients and health systems alike.
Mayo Clinic (Pharmacogenomics: Precision Medicine and Drug Response) “there can no longer be any doubt that drug efficacy and the occurrence of adverse drug reactions can both be influenced by genomics or that genomic information can be used to help maximize efficacy and minimize the occurrence of adverse drug reactions”.
Pharmacogenomics: Precision Medicine and Drug Response
Pro-GeneX maximizes patient experience opportunities and address patients’ concerns or discomfort by utilizing our ultra-rapid testing solutions. Faster, better, more accurate testing improves the quality of care and overall patient experience.
The MyBestMed® test after admission helps identify adverse drug events that might occur with a patient population. Having the Pro-GeneX Clinical team on your side gives you an edge to protect residents.
PGx allows a provider to take a personalized medicine approach to prescribing resulting in improved outcomes and patient compliance.
Pro-GeneX is more than just a laboratory company. We couple state-of-the-art molecular technologies with strong clinical decision support tools to effectively provide risk management assistance to our clients. Since inception, our testing solutions have grown exponentially due to advances in science and clinical experience. This growth has heightened interest in integrating these discoveries into clinical practice and automated decision-making systems. Our goal is to help providers maximize efficacy of treatments by delivering rapid diagnostics and higher accuracy to improve confidence in results and reduce time to achieve effective therapy for patients.
